Results 221 to 230 of about 8,093,285 (389)

Decrypting cancer's spatial code: from single cells to tissue niches

open access: yesMolecular Oncology, EarlyView.
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik   +4 more
wiley   +1 more source

Oh, the Places We’ll Go: Patient-Reported Outcomes and Electronic Health Records

open access: yesPatient, 2018
Sarah G. Gensheimer   +4 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Validating Patient-Reported Outcomes and Surveys in Other Languages. [PDF]

open access: yesCurr Rev Musculoskelet Med
Kwok VE, Diaz A, Grellinger E, Swarup I.
europepmc   +1 more source

Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction

open access: yesJournal of the National Cancer Institute, 2018
R. Jagsi   +7 more
semanticscholar   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Reimagining patient-reported outcomes in the age of generative AI. [PDF]

open access: yesNPJ Digit Med
Boyer L   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy